Home › Funds › Knights of Columbus Asset Advisors LLC › GILD

Knights of Columbus Asset Advisors LLC position in GILD

GILEAD SCIENCES INC · Health Care

Knights of Columbus Asset Advisors LLC reported holding 114,329 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$17.0M, representing 0.85% of its reported portfolio and ranking #23 among its reported holdings. Knights of Columbus Asset Advisors LLC has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)114.33K sh
Reported value held$17.04M
Portfolio Weight0.85%
First reportedQ2 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Knights of Columbus Asset Advisors LLC's GILD position evolved

Knights of Columbus Asset Advisors LLC first disclosed a stake in GILD in Q2 2024 at 150 shares (US$10K). The position peaked in Q3 2026 at 114,329 shares, worth US$17.0M. Across 10 filings, Knights of Columbus Asset Advisors LLC increased the stake 7 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 114,329 shares valued at US$17.0M — an increase of 4,617 shares quarter over quarter.. Notable position changes include a 18865% increase in Q1 2025 (shares were roughly flat over the following quarter), a 94% increase in Q3 2025 (shares rose 10% over the following quarter), a 83% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 150 $10.29K New
Q3 2024 150 $12.58K Hold
Q4 2024 150 $13.86K Hold
Q1 2025 28.45K $3.19M Add
Q2 2025 28.86K $3.20M Add
Q3 2025 56.12K $6.23M Add
Q4 2025 57.54K $7.06M Add
Q1 2026 59.91K $8.35M Add
Q2 2026 109.71K $13.86M Add
Q3 2026 114.33K $17.04M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Knights of Columbus Asset Advisors LLC held GILD?

Knights of Columbus Asset Advisors LLC has disclosed GILD holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is Knights of Columbus Asset Advisors LLC's current position in GILD?

As of Q3 2026, Knights of Columbus Asset Advisors LLC holds 114.33K shares of GILD (GILEAD SCIENCES INC), valued at $17.04M, representing 0.85% of its reported portfolio and ranking #23.

Has Knights of Columbus Asset Advisors LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), Knights of Columbus Asset Advisors LLC increased its position in GILD. The position peaked in Q3 2026 at 114.33K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.